Chapter 15: Allergic rhinitis.

Area of Science:

• Immunology
• Allergology
• Otolaryngology

Background:

• Allergic rhinitis affects 60 million in the U.S. and 1.4 billion globally, with increasing prevalence.
• Symptoms significantly impair quality of life, sleep, and productivity, and are linked to comorbidities like asthma and sinusitis.
• The condition involves a complex, allergen-driven mucosal inflammatory process mediated by immunoglobulin E (IgE).

Purpose of the Study:

• To review the diagnosis and management of allergic rhinitis.
• To highlight the impact of allergic rhinitis on patient well-being and associated health issues.
• To discuss current therapeutic strategies for allergic rhinitis.

Main Methods:

• Diagnosis relies on a thorough allergic history, physical examination, and specific IgE antibody assessment via skin testing or in vitro assays.
• Management strategies include environmental exposure modification, pharmacotherapy, and allergen-specific immunotherapy.
• Pharmacotherapy options include intranasal antihistamines, corticosteroids, anticholinergic agents, mast cell stabilizers, saline, and decongestants.

Main Results:

• Intranasal corticosteroids and intranasal antihistamines are the most effective pharmacotherapies for allergic rhinitis.
• Combination therapy (separate or fixed-dose) can be used for persistent or difficult-to-control allergic rhinitis.
• Management selection is guided by symptom severity and chronicity.

Conclusions:

• Allergic rhinitis is a prevalent condition with significant impact on patients' lives.
• A comprehensive approach combining accurate diagnosis with tailored management strategies is crucial.
• Effective treatment options are available to alleviate symptoms and improve patient outcomes.